Rachel A. Collins

17 papers receiving 726 citations

Peers

Rachel A. Collins
Comparison fields: 5 of 106
  • Pulmonary and Respiratory Medicine 266
  • Physiology 183
  • Molecular Biology 162
  • Health, Toxicology and Mutagenesis 149
  • Immunology 86
Replace Koustav Ganguly with:
Koustav Ganguly Sweden
Elena C. Castillo Mexico
Changshi Xie Canada
Jin Young Jung South Korea
Maciej Chałubiński Poland
Karuthapillai Govindaraju Canada
Gianvico Melzi d’Eril Italy
Toby K. McGovern Canada
Francine Uwambayinema Belgium
Mary Buford United States
Rachel A. Collins relative to Koustav Ganguly Sweden Koustav Ganguly's profile →
Citations per field
00.5×1.5×
Koustav Ganguly · 1×
Citations per year

Countries citing papers authored by Rachel A. Collins

Since Specialization
Citations

This map shows the geographic impact of Rachel A. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel A. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel A. Collins more than expected).

Fields of papers citing papers by Rachel A. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel A. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel A. Collins. The network helps show where Rachel A. Collins may publish in the future.

Co-authorship network of co-authors of Rachel A. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel A. Collins. A scholar is included among the top collaborators of Rachel A. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel A. Collins. Rachel A. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 20
2 11
3 6
4 4
5 26
6 26
7 20
8 18
9 16
10 36
11 50
12 94
13 98
14 141
15 131
16 46
17 3

About Rachel A. Collins

Rachel A. Collins is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Endocrine and Autonomic Systems, having authored 17 papers that have together received 746 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (9 papers), Inhalation and Respiratory Drug Delivery (6 papers) and Respiratory viral infections research (3 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (149 citations), Rehabilitation (58 citations) and Pulmonary and Respiratory Medicine (266 citations). Rachel A. Collins has collaborated with scholars based in Australia, Hungary and United States. Frequent co-authors include Miranda D. Grounds, Peter D. Sly, Debra J. Turner, John B. Vincent, Zoltán Hantos, Stephen A. Woski, Cindy Thamrin, N.E. Chakov, Tibor Z. Jánosi and Machiko Ikegami. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Applied Physiology and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026